Concepedia

An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study

David Eldred‐Evans, Henry Tam, Heminder Sokhi, Anwar R. Padhani, Martin J. Connor, Derek Price, Martin Gammon, Natalia Klimowska‐Nassar, Paula Burak, Emily Day,

European Urology Oncology · 2023 · 22 citations · 16 references

DOIFull text

Open access

Abstract

The IP1-PROSTAGRAM study shows that PROSTAGRAM magnetic resonance imaging in men with a prostate-specific antigen level of ≥1.0 ng/ml could be a promising pathway to evaluate in future screening trials.

References

16

Mortality Results from a Randomized Prostate-Cancer Screening Trial

Gerald L. Andriole, E. David Crawford, Robert L. Grubb et al. · New England Journal of Medicine · 2009 · 2.9K citations · Full text

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

Michael Ahdoot, Andrew R. Wilbur, Sarah E. Reese et al. · New England Journal of Medicine · 2020 · 835 citations · Full text

Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower

Ian M. Thompson · JAMA · 2005 · 688 citations

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Jonas Hugosson, Monique J. Roobol, Marianne Månsson et al. · European Urology · 2019 · 669 citations · Full text

, , +8

European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

Endoscopy · 2012 · 525 citations · Full text

, , +17